Clinical development plan: oltipraz.
Kelloff
G J
GJ
Chemoprevention Branch, National Cancer Institute (NCI), Bethesda, MD 20892, USA.
Crowell
J A
JA
Boone
C W
CW
Steele
V E
VE
Lubet
R A
RA
Greenwald
P
P
Alberts
D S
DS
Covey
J M
JM
Doody
L A
LA
Knapp
G G
GG
D000818:Animals; D016588:Anticarcinogenic Agents / Q000494:pharmacology; D002986:Clinical Trials as Topic / Q000379:methods* / Q000592:standards; D006224:Cricetinae; D004285:Dogs; D017277:Drug Approval; D006801:Humans; D051379:Mice; D011719:Pyrazines / Q000494:pharmacology* / Q000627:therapeutic use*; D011817:Rabbits; D051381:Rats; D013871:Thiones; D013876:Thiophenes
D016588:Anticarcinogenic Agents; D011719:Pyrazines; D013871:Thiones; D013876:Thiophenes; C026209:oltipraz